Kalsitonin gen-relateret protein (Norwegian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Kalsitonin gen-relateret protein" in Norwegian language version.

refsWebsite

Global rank Norwegian rank

4doi.org

2^nd place

9^th place

2nih.gov

4^th place

23^rd place

1nejm.org

2,374^th place

3,358^th place

1sciencealert.com

5,043^rd place

low place

1theconversation.com

928^th place

4,762^nd place

1ecronicon.com

low place

1web.archive.org

1^st place

doi.org (Global: 2^nd place; Norwegian: 9^th place)

Gelfand, A. A., & Goadsby, P. J. (2018). Cluster Headache and Calcitonin Gene-Related Peptide—More on Quantum Therapeutics in Headache Medicine. JAMA neurology. DOI:10.1001/jamaneurol.2018.1428
Do, T. P., Guo, S., & Ashina, M. (2019). Therapeutic novelties in migraine: new drugs, new hope?. The journal of headache and pain, 20(1), 37. doi:10.1186/s10194-019-0974-3
Silberstein, S. D., Dodick, D. W., Bigal, M. E., Yeung, P. P., Goadsby, P. J., Blankenbiller, T., ... & Aycardi, E. (2017). Fremanezumab for the preventive treatment of chronic migraine. New England Journal of Medicine, 377(22), 2113-2122. doi:10.1056/NEJMoa1709038
Tepper, S.J. (2019). CGRP and headache: a brief review. Neurol Sci. https://doi.org/10.1007/s10072-019-03769-8

ecronicon.com (Global: low place; Norwegian: low place)

Saumya H Mittal. “CGRP, Current Focus in Migraine Arkivert 26. januar 2019 hos Wayback Machine.”. EC Neurology 11.2 (2019): 132-136

nejm.org (Global: 2,374^th place; Norwegian: 3,358^th place)

Silberstein, S. D., Dodick, D. W., Bigal, M. E., Yeung, P. P., Goadsby, P. J., Blankenbiller, T., ... & Aycardi, E. (2017). Fremanezumab for the preventive treatment of chronic migraine. New England Journal of Medicine, 377(22), 2113-2122. doi:10.1056/NEJMoa1709038

nih.gov (Global: 4^th place; Norwegian: 23^rd place)

ncbi.nlm.nih.gov

Monteith D, Collins EC, Vandermeulen C, Van Hecken A, Raddad E, Scherer JC, Grayzel D, Schuetz TJ, de Hoon J: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers. Front Pharmacol. 2017 Oct 17;8:740. doi: 10.3389/fphar.2017.00740. eCollection 2017. PubMed:29089894
Dodick DW, Goadsby PJ, Silberstein SD, Lipton RB, Olesen J, Ashina M, Wilks K, Kudrow D, Kroll R, Kohrman B, Bargar R, Hirman J, Smith J: Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial. Lancet Neurol. 2014 Nov;13(11):1100-1107. doi: 10.1016/S1474-4422(14)70209-1. Epub 2014 Oct 5. PubMed:25297013

sciencealert.com (Global: 5,043^rd place; Norwegian: low place)

Dean, Signe (4. desember 2017). These Groundbreaking Migraine Prevention Drugs Just Smashed Clinical Trials. Science Alert. Besøkt 2018-09-29.

theconversation.com (Global: 928^th place; Norwegian: 4,762^nd place)

Lloyd, Katie A (4. januar 2018). The first effective drugs for preventing migraine may be available soon. The Conversation. Besøkt 2018-09-29.

web.archive.org (Global: 1^st place; Norwegian: 1^st place)

Saumya H Mittal. “CGRP, Current Focus in Migraine Arkivert 26. januar 2019 hos Wayback Machine.”. EC Neurology 11.2 (2019): 132-136

Kalsitonin gen-relateret protein (Norwegian Wikipedia)

doi.org (Global: 2nd place; Norwegian: 9th place)

ecronicon.com (Global: low place; Norwegian: low place)

nejm.org (Global: 2,374th place; Norwegian: 3,358th place)

nih.gov (Global: 4th place; Norwegian: 23rd place)